Element Capital Management LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Element Capital Management LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,934 shares of the company’s stock, valued at approximately $5,086,000. HCA Healthcare makes up approximately 7.2% of Element Capital Management LLC’s portfolio, making the stock its 6th biggest position.

Other institutional investors also recently bought and sold shares of the company. Cerity Partners LLC raised its position in HCA Healthcare by 13.1% during the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after acquiring an additional 5,092 shares during the last quarter. Swiss National Bank increased its stake in shares of HCA Healthcare by 4.3% during the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after purchasing an additional 23,100 shares in the last quarter. National Pension Service lifted its stake in HCA Healthcare by 2.9% in the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after buying an additional 17,531 shares in the last quarter. Savant Capital LLC increased its position in HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after buying an additional 1,246 shares in the last quarter. Finally, Sector Gamma AS lifted its position in shares of HCA Healthcare by 36.0% in the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after acquiring an additional 2,883 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently weighed in on HCA shares. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. TD Cowen boosted their price objective on shares of HCA Healthcare from $529.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, March 10th. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research report on Friday, January 30th. Royal Bank Of Canada increased their price target on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Finally, Leerink Partners lifted their price objective on HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $537.73.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 15,214 shares of company stock worth $7,797,595. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $533.39 on Friday. The firm has a market capitalization of $119.28 billion, a price-to-earnings ratio of 18.79, a price-to-earnings-growth ratio of 1.64 and a beta of 1.34. The company has a 50 day moving average price of $507.05 and a 200 day moving average price of $470.03. HCA Healthcare, Inc. has a one year low of $313.21 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the previous year, the company earned $6.22 EPS. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is presently 10.15%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.